Does low-dose intracoronary streptokinase improve myocardial reperfusion and long-term left ventricular size or function in patients undergoing primary PCI?
Patients undergoing primary percutaneous coronary intervention (PCI)
Low-dose intracoronary streptokinase administered immediately after primary PCI
Myocardial reperfusion and long-term left ventricular size or functionsurrogate
Low-dose intracoronary streptokinase after primary PCI improves myocardial reperfusion but does not translate to long-term improvements in left ventricular size or function.
In our pilot trial, the administration of low-dose intracoronary streptokinase immediately after primary PCI improved myocardial reperfusion but not long-term left ventricular size or function. These findings require clarification in a larger trial. (ClinicalTrials.gov number, NCT00302419.)
Building similarity graph...
Analyzing shared references across papers
Loading...
Murat Sezer
Hüseyin Oflaz
Taner Gören
New England Journal of Medicine
Istanbul University
Istanbul Şehir University
Building similarity graph...
Analyzing shared references across papers
Loading...
Sezer et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69d5715775589c71d767e08a — DOI: https://doi.org/10.1056/nejmoa054374